経鼻ドラッグデリバリー技術の世界市場レポート 2025年

経鼻ドラッグデリバリー技術市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）8.6％で1,195億6,000万米ドルに成長します。予測期間の成長は、生物製剤とペプチド療法の増加、小児と老年患者のニーズへの注目、製薬業界における提携と協力、一般用（OTC）点鼻薬の拡大、精密医療への注目の高まりに起因すると考えられます。予測期間における主な動向としては、製剤技術の進歩、患者に優しいデバイスへの注目の高まり、治療領域の拡大、生物製剤とペプチドの送達、鼻腔スプレー技術の革新などが挙げられます。

慢性疾患の増加は、経鼻ドラッグデリバリー技術市場の成長を刺激すると予測されます。慢性疾患は、1年以上持続し、継続的な医療を必要とする健康状態と定義され、日常活動を制限する可能性があります。経鼻ドラッグデリバリー技術は、慢性鼻副鼻腔炎を管理するために利用され、鼻腔の複雑な構造に合わせた治療アプローチを通じて、細菌バイオフィルム管理と粘膜クリアランスを強化します。例えば、米国に本部を置く非営利の医療団体である米国心臓病学会（American College of Cardiology）が2022年8月に発表した報告書によると、4つの主要な心血管危険因子すべてが2025年から2060年にかけて増加すると予想されています。なかでも糖尿病は39.3％増加し、5,500万人に達すると予測されています。次いで脂質異常症（27.6％増の1億2,600万人）、高血圧（25.1％増の1億6,200万人）、肥満（18.3％増の1億2,600万人）が続く。さらに、脳卒中（33.8％増の1,500万人）、心不全（33.4％増の1,300万人）、虚血性心疾患（30.7％増の2,900万人）、心臓発作（16.9％増の1,600万人）など、心血管疾患の大幅な増加が予想されます。その結果、慢性疾患の有病率の増加が経鼻ドラッグデリバリーシステム市場の拡大に拍車をかけています。

経鼻ドラッグデリバリー技術市場の成長は、世界の老人人口の増加によって牽引されると予測されます。老年人口は、一般的に65歳以上の個人で構成されています。このドラッグデリバリー方式は、その使いやすさと患者の服薬アドヒアランスの向上により、高齢者の間で支持されており、この年齢層における錠剤の嚥下に関する困難を克服するのに役立っています。例えば、2024年1月、統計の収集と提供に重点を置く米国の非営利団体である人口問題研究所は、65歳以上の米国人の数が2022年の5,800万人から2050年には8,200万人になり、47％増加すると予測しています。さらに、65歳以上の人口比率は17％から23％に上昇すると予想されています。その結果、世界の老人人口の増加が経鼻ドラッグデリバリー技術市場の拡大に寄与することになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界経鼻ドラッグデリバリー技術 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の経鼻ドラッグデリバリー技術市場：成長率分析
• 世界の経鼻ドラッグデリバリー技術市場の実績：規模と成長, 2019-2024
• 世界の経鼻ドラッグデリバリー技術市場の予測：規模と成長, 2024-2029, 2034F
• 世界経鼻ドラッグデリバリー技術総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の経鼻ドラッグデリバリー技術市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鼻スプレー
• 点鼻薬
• 鼻用ジェルと軟膏
• 点鼻薬
• その他の剤形
• 世界の経鼻ドラッグデリバリー技術市場コンテナタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 加圧容器
• 非加圧容器
• 世界の経鼻ドラッグデリバリー技術市場治療用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アレルギー性および非アレルギー性鼻炎
• 鼻づまり
• 喘息
• 予防接種
• その他の治療用途
• 世界の経鼻ドラッグデリバリー技術市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の経鼻ドラッグデリバリー技術市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホームケア設定
• 病院
• 世界の経鼻ドラッグデリバリー技術市場、鼻スプレーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定量噴霧式スプレー
• 定量噴霧式でないスプレー
• 世界の経鼻ドラッグデリバリー技術市場点鼻薬の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 液体点鼻薬
• ジェルベースの点鼻薬
• 世界の経鼻ドラッグデリバリー技術市場、鼻用ジェルと軟膏の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハイドロゲル製剤
• 油性軟膏
• 世界の経鼻ドラッグデリバリー技術市場、点鼻薬の種類別細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドライパウダー吸入器（DPI）
• スプレー乾燥粉末
• 世界の経鼻ドラッグデリバリー技術市場、その他の剤形のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鼻パッチ
• 鼻挿入物

第7章 地域別・国別分析

• 世界の経鼻ドラッグデリバリー技術市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の経鼻ドラッグデリバリー技術市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 経鼻ドラッグデリバリー技術市場：競合情勢
• 経鼻ドラッグデリバリー技術市場：企業プロファイル
  • AptarGroup Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pfizer Inc.
• 3M Company
• Cadila Healthcare Limited
• Neurelis Inc.
• OptiNose Inc.
• Bausch Health Companies Inc.
• Naveh Pharma Ltd.
• Teva Pharmaceutical Industries Ltd.
• Consort Medical plc
• Douglas Pharmaceuticals Ltd.
• ENT Technologies Pty. Ltd.
• Merck & Co. Inc.
• Sanofi SA
• AstraZeneca plc
• Boehringer Ingelheim International GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 経鼻ドラッグデリバリー技術市場2029：新たな機会を提供する国
• 経鼻ドラッグデリバリー技術市場2029：新たな機会を提供するセグメント
• 経鼻ドラッグデリバリー技術市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Nasal drug delivery technology involves administering pharmaceuticals through the nasal cavity, aiming to rapidly achieve therapeutic drug levels in the bloodstream and potentially enable direct drug delivery to the brain via olfactory neurons. This method bypasses the blood-brain barrier (BBB) and undergoes minimal processing in the liver and intestines.

Key dosage forms for this technology include nasal spray, nasal drops, nasal gels, ointments, powders, and others. Nasal spray devices expel numerous tiny liquid drops to cleanse the nose or deliver medication to the body. They are available in pressurized and non-pressurized containers and are applied across diverse uses such as allergic and non-allergic rhinitis, nasal congestion, asthma, vaccination, and more. These products are accessible through various distribution channels such as hospital pharmacies, retail outlets, and online pharmacies, and are utilized by end-users including home care settings and hospitals.

The nasal drug delivery technology market research report is one of a series of new reports from The Business Research Company that provides nasal drug delivery technology market statistics, including nasal drug delivery technology industry global market size, regional shares, competitors with a nasal drug delivery technology market share, detailed nasal drug delivery technology market segments, market trends, and opportunities, and any further data you may need to thrive in the nasal drug delivery technology industry. This nasal drug delivery technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nasal drug delivery technology market size has grown strongly in recent years. It will grow from$80.79 billion in 2024 to $85.89 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to advancements in drug formulations, increasing prevalence of respiratory disorders, patient preference for non-invasive delivery, expanding geriatric population, regulatory support for nasal drug approvals

The nasal drug delivery technology market size is expected to see strong growth in the next few years. It will grow to $119.56 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rise in biologics and peptide therapies, focus on pediatric and geriatric patient needs, partnerships and collaborations in the pharma industry, expansion of over-the-counter (OTC) nasal products, increased focus on precision medicine. Major trends in the forecast period include advancements in formulation technology, increased focus on patient-friendly devices, expansion of therapeutic areas, biologics and peptides delivery, innovations in nasal spray technologies.

The rising prevalence of chronic diseases is projected to stimulate growth in the nasal drug delivery technology market. Chronic diseases are defined as health conditions that persist for a year or more and necessitate continuous medical care, potentially limiting daily activities. Nasal drug delivery technologies are utilized to manage chronic rhinosinusitis, enhancing bacterial biofilm management and mucociliary clearance through a therapeutic approach tailored for the intricate structure of the nasal cavity. For example, a report by the American College of Cardiology, a nonprofit medical association based in the United States, published in August 2022, indicates that all four primary cardiovascular risk factors are expected to rise from 2025 to 2060. Among these, diabetes is anticipated to experience the most significant increase, rising by 39.3% to reach 55 million individuals. This is followed by dyslipidemia (up 27.6% to 126 million), hypertension (up 25.1% to 162 million), and obesity (up 18.3% to 126 million). Furthermore, substantial rises in cardiovascular disease rates are expected, including stroke (33.8% increase to 15 million) and heart failure (33.4% increase to 13 million), with ischemic heart disease (up 30.7% to 29 million) and heart attack (up 16.9% to 16 million) not far behind. As a result, the increasing prevalence of chronic diseases is fueling the expansion of the nasal drug delivery systems market.

The growth of the nasal drug delivery technology market is anticipated to be driven by the increasing global geriatric population. The geriatric population consists of individuals who are generally 65 years old and above. This drug delivery method is favored among older adults due to its ease of use and improved patient adherence, helping to overcome difficulties associated with pill swallowing in this age group. For example, in January 2024, the Population Reference Bureau, a nonprofit organization in the US that focuses on collecting and providing statistics, projected that the number of Americans aged 65 and older will grow from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, the proportion of the population aged 65 and older is expected to rise from 17% to 23%. Consequently, the increase in the geriatric population worldwide will contribute to the expansion of the nasal drug delivery technology market.

Product innovation stands as a pivotal trend shaping the landscape of nasal drug delivery technology. Leading pharmaceutical companies are actively engaged in developing novel drug administration methods to bolster their market positions. For instance, in January 2023, AptarGroup, Inc. introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray designed for nasal saline and equivalent OTC formulations. This innovative product's recyclability design has garnered Class AA certification, promoting greater recycling efficiency.

Collaborative efforts aimed at technological advancements highlight the strategic focus within the nasal drug delivery sector. Notably, in November 2023, Hovione collaborated with Industrial Design Consultancy (IDC) to develop advanced nasal powder delivery devices. These devices offer precise drug delivery options for local, systemic, or nose-to-brain applications, showcasing versatility and reliability. The collaboration's objective is to expedite the release of two innovative nasal powder delivery devices, catering to diverse drug delivery needs while streamlining drug product development and manufacturing processes.

In May 2022, Medtronic plc, a US-based medical device firm, acquired Intersect ENT Inc. for an undisclosed sum. The acquisition will add novel products used in sinus operations to enhance post-operative outcomes and treat nasal polyps to Medtronic's entire ear, nose, and throat (ENT) portfolio. Intersect ENT Inc. is a US-based medical device firm operating in ear, nose, and throat medical technology.

Major companies operating in the nasal drug delivery technology market include AptarGroup Inc., Becton Dickinson and Company, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Novartis AG, Pfizer Inc., 3M Company, Cadila Healthcare Limited, Neurelis Inc., OptiNose Inc., Bausch Health Companies Inc., Naveh Pharma Ltd., Teva Pharmaceutical Industries Ltd., Consort Medical plc, Douglas Pharmaceuticals Ltd., ENT Technologies Pty. Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Boehringer Ingelheim International GmbH, Bayer AG, Abbott Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., Biogen Inc., Roche Holding AG, Allergan plc, Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals Inc.

North America was the largest region in the nasal drug delivery technology market in 2024. The regions covered in the nasal drug delivery technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the nasal drug delivery technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The nasal drug delivery technology market consists of revenues earned by entities by providing services such as intranasal drug delivery services, brain-targeted therapy, and mucosal vaccination. The market value includes the value of related goods sold by the service provider or included within the service offering. The nasal drug delivery technology market also includes sales of catheter-delivered drugs, nebulizers, and pressurized metered-dose inhalers (PMDIs) equipment which are used in providing nasal drug delivery technology services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nasal Drug Delivery Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nasal drug delivery technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nasal drug delivery technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nasal drug delivery technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Dosage Form: Nasal Spray; Nasal Drops; Nasal Gels And Ointments; Nasal Powders; Other Dosage Forms
• 2) By Container Type: Pressurized Containers; Non-Pressurized Containers
• 3) By Therapeutic Application: Allergic And Non-Allergic Rhinitis; Nasal Congestion; Asthma; Vaccination; Other Therapeutic Applications
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Home Care Settings; Hospitals
• Subsegments:
• 1) By Nasal Spray: Metered-Dose Spray; Non-Metered-Dose Spray
• 2) By Nasal Drops: Liquid Nasal Drops; Gel-Based Nasal Drops
• 3) By Nasal Gels and Ointments: Hydrogel Formulations; Oil-Based Ointments
• 4) By Nasal Powders: Dry Powder Inhalers (DPI); Spray-Dried Powders
• 5) By Other Dosage Forms: Nasal Patches; Nasal Inserts
• Companies Mentioned: AptarGroup Inc.; Becton Dickinson and Company; GlaxoSmithKline plc; Johnson & Johnson Private Limited; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nasal Drug Delivery Technology Market Characteristics

3. Nasal Drug Delivery Technology Market Trends And Strategies

4. Nasal Drug Delivery Technology Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Nasal Drug Delivery Technology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nasal Drug Delivery Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nasal Drug Delivery Technology Market Growth Rate Analysis
• 5.4. Global Nasal Drug Delivery Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nasal Drug Delivery Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nasal Drug Delivery Technology Total Addressable Market (TAM)

6. Nasal Drug Delivery Technology Market Segmentation

• 6.1. Global Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nasal Spray
• Nasal Drops
• Nasal Gels And Ointments
• Nasal Powders
• Other Dosage Forms
• 6.2. Global Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pressurized Containers
• Non-Pressurized Containers
• 6.3. Global Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergic And Non-Allergic Rhinitis
• Nasal Congestion
• Asthma
• Vaccination
• Other Therapeutic Applications
• 6.4. Global Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Home Care Settings
• Hospitals
• 6.6. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Spray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered-Dose Spray
• Non-Metered-Dose Spray
• 6.7. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Drops, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Nasal Drops
• Gel-Based Nasal Drops
• 6.8. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Gels and Ointments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrogel Formulations
• Oil-Based Ointments
• 6.9. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Powders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dry Powder Inhalers (DPI)
• Spray-Dried Powders
• 6.10. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nasal Patches
• Nasal Inserts

7. Nasal Drug Delivery Technology Market Regional And Country Analysis

• 7.1. Global Nasal Drug Delivery Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nasal Drug Delivery Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nasal Drug Delivery Technology Market

• 8.1. Asia-Pacific Nasal Drug Delivery Technology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nasal Drug Delivery Technology Market

• 9.1. China Nasal Drug Delivery Technology Market Overview
• 9.2. China Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nasal Drug Delivery Technology Market

• 10.1. India Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nasal Drug Delivery Technology Market

• 11.1. Japan Nasal Drug Delivery Technology Market Overview
• 11.2. Japan Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nasal Drug Delivery Technology Market

• 12.1. Australia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nasal Drug Delivery Technology Market

• 13.1. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nasal Drug Delivery Technology Market

• 14.1. South Korea Nasal Drug Delivery Technology Market Overview
• 14.2. South Korea Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nasal Drug Delivery Technology Market

• 15.1. Western Europe Nasal Drug Delivery Technology Market Overview
• 15.2. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nasal Drug Delivery Technology Market

• 16.1. UK Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nasal Drug Delivery Technology Market

• 17.1. Germany Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nasal Drug Delivery Technology Market

• 18.1. France Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nasal Drug Delivery Technology Market

• 19.1. Italy Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nasal Drug Delivery Technology Market

• 20.1. Spain Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nasal Drug Delivery Technology Market

• 21.1. Eastern Europe Nasal Drug Delivery Technology Market Overview
• 21.2. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nasal Drug Delivery Technology Market

• 22.1. Russia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nasal Drug Delivery Technology Market

• 23.1. North America Nasal Drug Delivery Technology Market Overview
• 23.2. North America Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nasal Drug Delivery Technology Market

• 24.1. USA Nasal Drug Delivery Technology Market Overview
• 24.2. USA Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nasal Drug Delivery Technology Market

• 25.1. Canada Nasal Drug Delivery Technology Market Overview
• 25.2. Canada Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nasal Drug Delivery Technology Market

• 26.1. South America Nasal Drug Delivery Technology Market Overview
• 26.2. South America Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nasal Drug Delivery Technology Market

• 27.1. Brazil Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nasal Drug Delivery Technology Market

• 28.1. Middle East Nasal Drug Delivery Technology Market Overview
• 28.2. Middle East Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nasal Drug Delivery Technology Market

• 29.1. Africa Nasal Drug Delivery Technology Market Overview
• 29.2. Africa Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nasal Drug Delivery Technology Market Competitive Landscape And Company Profiles

• 30.1. Nasal Drug Delivery Technology Market Competitive Landscape
• 30.2. Nasal Drug Delivery Technology Market Company Profiles
  • 30.2.1. AptarGroup Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Nasal Drug Delivery Technology Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. 3M Company
• 31.3. Cadila Healthcare Limited
• 31.4. Neurelis Inc.
• 31.5. OptiNose Inc.
• 31.6. Bausch Health Companies Inc.
• 31.7. Naveh Pharma Ltd.
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Consort Medical plc
• 31.10. Douglas Pharmaceuticals Ltd.
• 31.11. ENT Technologies Pty. Ltd.
• 31.12. Merck & Co. Inc.
• 31.13. Sanofi SA
• 31.14. AstraZeneca plc
• 31.15. Boehringer Ingelheim International GmbH

32. Global Nasal Drug Delivery Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nasal Drug Delivery Technology Market

34. Recent Developments In The Nasal Drug Delivery Technology Market

35. Nasal Drug Delivery Technology Market High Potential Countries, Segments and Strategies

• 35.1 Nasal Drug Delivery Technology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nasal Drug Delivery Technology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nasal Drug Delivery Technology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer